585 related articles for article (PubMed ID: 27261908)
21. The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.
Micke P; Mattsson JS; Djureinovic D; Nodin B; Jirström K; Tran L; Jönsson P; Planck M; Botling J; Brunnström H
J Thorac Oncol; 2016 Jun; 11(6):862-72. PubMed ID: 26872818
[TBL] [Abstract][Full Text] [Related]
22. Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors.
Kobayashi Y; Tokuchi Y; Hashimoto T; Hayashi M; Nishimura H; Ishikawa Y; Nakagawa K; Sato Y; Takahashi A; Tsuchiya E
Cancer Sci; 2004 Apr; 95(4):334-41. PubMed ID: 15072592
[TBL] [Abstract][Full Text] [Related]
23. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
Wolin EM
Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
[TBL] [Abstract][Full Text] [Related]
24. [Neuroendocrine tumors of the stomach. Pathogenesis, classification and clinical aspects].
Bordi C; Azzoni C; D'Adda T; Caruana P; Carlinfante G
Pathologe; 1997 Jul; 18(4):313-21. PubMed ID: 9380606
[TBL] [Abstract][Full Text] [Related]
25. Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives?
Scoazec JY
Ann Endocrinol (Paris); 2019 Jun; 80(3):163-165. PubMed ID: 31064659
[TBL] [Abstract][Full Text] [Related]
26. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
Li JK; Wang M; Yuan J; Song ZG
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
[No Abstract] [Full Text] [Related]
27. Quantitative nuclear texture features analysis confirms WHO classification 2004 for lung carcinomas.
Schmid K; Angerstein N; Geleff S; Gschwendtner A
Mod Pathol; 2006 Mar; 19(3):453-9. PubMed ID: 16462732
[TBL] [Abstract][Full Text] [Related]
28. [Update of pathological diagnosis of pulmonary neuroendocrine tumor].
Teng X; Zhao M; Lai M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):36-44. PubMed ID: 27045239
[TBL] [Abstract][Full Text] [Related]
29. Reporting lung cancer pathology specimens. Impact of the anticipated 7th Edition TNM classification based on recommendations of the IASLC Staging Committee.
Travis WD;
Histopathology; 2009 Jan; 54(1):3-11. PubMed ID: 19187176
[TBL] [Abstract][Full Text] [Related]
30. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?
Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M
Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and management of typical and atypical lung carcinoids.
Pusceddu S; Lo Russo G; Macerelli M; Proto C; Vitali M; Signorelli D; Ganzinelli M; Scanagatta P; Duranti L; Trama A; Buzzoni R; Pelosi G; Pastorino U; de Braud F; Garassino MC
Crit Rev Oncol Hematol; 2016 Apr; 100():167-76. PubMed ID: 26917456
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary Neuroendocrine Tumors.
Borczuk AC
Surg Pathol Clin; 2020 Mar; 13(1):35-55. PubMed ID: 32005434
[TBL] [Abstract][Full Text] [Related]
33. [Pathology of lung neuroendocrine tumors].
Fillinger J
Magy Onkol; 2018 Jul; 62(2):83-89. PubMed ID: 30027935
[TBL] [Abstract][Full Text] [Related]
34. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
35. [Morphological and immunohistochemical observations on 30 cases of neuroendocrine carcinoma of the lung].
Li WH
Zhonghua Bing Li Xue Za Zhi; 1993 Aug; 22(4):197-200. PubMed ID: 8168174
[TBL] [Abstract][Full Text] [Related]
36. Recent advances and conceptual changes in the classification of neuroendocrine tumors of the thymus.
Bohnenberger H; Ströbel P
Virchows Arch; 2021 Jan; 478(1):129-135. PubMed ID: 33555458
[TBL] [Abstract][Full Text] [Related]
37. High-grade Neuroendocrine Carcinoma of the Lung With Carcinoid Morphology: A Study of 12 Cases.
Quinn AM; Chaturvedi A; Nonaka D
Am J Surg Pathol; 2017 Feb; 41(2):263-270. PubMed ID: 27879513
[TBL] [Abstract][Full Text] [Related]
38. [Neuroendocrine tumors of the lungs. From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia].
Schnabel PA; Junker K
Pathologe; 2014 Nov; 35(6):557-64. PubMed ID: 25366372
[TBL] [Abstract][Full Text] [Related]
39. Histopathology of NET: Current concepts and new developments.
Schmitt AM; Blank A; Marinoni I; Komminoth P; Perren A
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):33-43. PubMed ID: 26971842
[TBL] [Abstract][Full Text] [Related]
40. Atypical course of typical lung carcinoid.
Jakubíková L
Klin Onkol; 2020; 33(4):302-308. PubMed ID: 32894960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
